Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality ...

That glowing triangle with an exclamation point inside it has probably caught your eye at the worst possible moment: merging onto a highway, idling in a parking lot, or pulling out of a driveway on a ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...

OMAHA, NE - January 21, 2026 - PRESSADVANTAGE - Kugler Vision has released a new educational article titled "SMILE vs ...